Michael Anstey
Chief Investment Officer bij Congenica Ltd.
Oorsprong van het eerstegraads netwerk van Michael Anstey
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Oxford
332
| College/University | Other Consumer Services | 332 |
Queen's University
219
| College/University | Other Consumer Services | 219 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.
154
| Private Company | Miscellaneous Commercial Services | 154 |
Cambridge Innovation Capital Ltd
 Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital Ltd (Cambridge Innovation Capital) is a venture capital firm founded in 2013. The firm is headquartered in Cambridge, United Kingdom.
47
| Private Company | Investment Managers | 47 |
| Public Company | Biotechnology | 19 | |
Start Codon Ltd.
 Start Codon Ltd. Investment ManagersFinance Start Codon Ltd (Start Codon) is a venture capital firm founded in 2018 by Jason Mellad and Marek Tyl. The firm is headquartered in London, United Kingdom.
10
| Holding Company | Investment Managers | 10 |
Congenica Ltd.
 Congenica Ltd. BiotechnologyHealth Technology Congenica Ltd. develops genome-based discovery and diagnostic technologies. It uses Sapientia technology platform, which allows genome scale DNA sequence data to be presented within a clinically actionable diagnostic report. The company was founded by Matthew Hurles, Richard Durbin and Philip Beales in 2013 and is headquartered in Hinxton, the United Kingdom.
10
| Holding Company | Biotechnology | 10 |
Polyprox Therapeutics Ltd.
 Polyprox Therapeutics Ltd. BiotechnologyHealth Technology Polyprox Therapeutics Ltd. operates as biotechnology company which engages in research and development of drugs to treat cancer and neurodegenerative diseases. The company was founded by Laura S. Itzhaki in 2018 and is headquartered in Cambridge, the United Kingdom.
4
| Holding Company | Biotechnology | 4 |
Sense Biodetection Ltd.
 Sense Biodetection Ltd. Medical/Nursing ServicesHealth Services Sense Biodetection Ltd. provides molecular diagnostics research services. It focuses on improving healthcare decisions and processes by developing novel, user-centred, handheld tests in the fields of infections and oncology. The company was founded by Harry John Lamble and Ralph Lamble in 2014 and is headquartered in Abingdon, the United Kingdom.
2
| Subsidiary | Medical/Nursing Services | 2 |
Buckman Laboratories SARL
 Buckman Laboratories SARL Chemicals: Major DiversifiedProcess Industries Buckman Laboratories SARL wholesales chemicals to the paint industry. The firm markets its products under the brand names such as BUCKMAN, BUFLOC, BULAB, BUSAN, BUSPERSE, and BUTROL. The company was founded on December 21, 2007 and is headquartered in Wasquehal, France.
1
| Subsidiary | Chemicals: Major Diversified | 1 |
Epitopea Ltd.
 Epitopea Ltd. Miscellaneous Commercial ServicesCommercial Services Epitopea Ltd. is a British transatlantic biotechnology company that develops immunotherapies to treat cancer by targeting a new class of antigens that are broadly shared between patients with the same cancer indication. The company is based in Cambridge, UK. The company has an extensive proprietary library of cryptigen™ tsas that will drive the development of transformational off the shelf cancer immunotherapies. Epitopea was founded in 2021 by Jonathan David Moore, Claude Perreault, and Pierre Thibault. Jonathan David Moore has been the CEO since 2021.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Michael Anstey via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| GE AEROSPACE | Industrial Machinery | Corporate Officer/Principal Corporate Officer/Principal | |
PharmaKodex Ltd.
 PharmaKodex Ltd. Pharmaceuticals: MajorHealth Technology PharmaKodex Ltd. develops pharmaceuticals products. It uses oral and transdermal drug delivery technologies to develop improved medicinal products. It develops and commercializes its products and technologies in an overlapping two component process. The company was founded in 2005 and is headquartered in Chippenham, UK | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member | |
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Founder | |
| POXEL | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Stanford University | College/University | Graduate Degree Masters Business Admin | |
| University of Bath | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer | |
GE Healthcare Ltd. (United Kingdom)
 GE Healthcare Ltd. (United Kingdom) Medical SpecialtiesHealth Technology GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom. | Medical Specialties | Corporate Officer/Principal Chief Executive Officer | |
| Newcastle University | College/University | Graduate Degree Doctorate Degree | |
| University of Toronto | College/University | Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| University of Bristol | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Comerica Ventures, Inc.
 Comerica Ventures, Inc. Investment ManagersFinance Comerica Ventures, Inc. (Comerica Ventures) is a venture capital subsidiary of Comerica, Inc. founded in 1977. The firm has headquarters in Palo Alto, California. | Investment Managers | Head-Equity Investments | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Director/Board Member Director/Board Member | |
Wellcome Trust Sanger Institute
 Wellcome Trust Sanger Institute BiotechnologyHealth Technology Wellcome Trust Sanger Institute provides genomic research services. It also provides research in the areas of cancer, agaeing, somatic mutation, cellular genetics, human genetics, infection genomics, and malaria. The company was founded in October 1993 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
DisplayLink Corp.
 DisplayLink Corp. Information Technology ServicesTechnology Services DisplayLink Corp. engages in the development of software compression technology. It offers universal docking stations, universal serial bus (USB) monitors, USB adapters, wireless virtual reality products, and meeting room systems. The company was founded by Martin King, Quentin Stafford-Fraser, Andrew Fisher, and Tim Glauert in 2003 and is headquartered in Palo Alto, CA. | Information Technology Services | Director of Finance/CFO | |
Hercules Capital
 Hercules Capital Investment ManagersFinance Hercules Capital is a venture capital firm founded in 2003 by Scott Harvey, Manuel Henriquez, and Roy Liu. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance Cambridge Enterprise Ltd.(CEL) is a Venture Capital firm, a subsidiary of University of Cambridge founded in 1972. Headquartered in Cambridge. | Investment Managers | Private Equity Investor Director/Board Member Private Equity Investor | |
The Bioindustry Association
 The Bioindustry Association Miscellaneous Commercial ServicesCommercial Services The BioIndustry Association is a UK-based organization that represents the life sciences and biotech industry. The British company's mission is to facilitate and connect the ecosystem to help businesses start, grow, and deliver world-changing innovation. The non-profit company was founded by Cormac G. Kilty and Simon Geoffrey Best, and Steve Bates has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Odyssey Ventures Ltd.
 Odyssey Ventures Ltd. Miscellaneous Commercial ServicesCommercial Services Odyssey Ventures Ltd. provides property management and business consulting services. The company was incorporated on February 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
| FRONTIER DEVELOPMENTS PLC | Recreational Products | Director/Board Member Director/Board Member Founder | |
Abcodia Ltd.
 Abcodia Ltd. BiotechnologyHealth Technology Abcodia Ltd. engages in the validation and discovery of molecular biomarkers. The firm works alongside University College London and in partnership with diagnostic, pharmaceutical and technology companies to exploit a prospective serum bank for the purpose of ethical biomarker validation and discovery. The company was founded in 2010 and is headquartered in London, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
MISSION Therapeutics Ltd.
 MISSION Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology MISSION Therapeutics Ltd. develops small molecule drugs targeting enzymes involved in cancer and other diseases. It focuses on selectively targeting deubiquitylating enzymes to treat cancer, neurodegenerative and other diseases. The company was founded by Stephen Jackson Philip, Xavier Jacq, Niall M. B. Martin and Keith Menear in 2011 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Atopix Therapeutics Ltd.
 Atopix Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Atopix Therapeutics Ltd. develops medicines to treat atopic dermatitis and severe asthma. The firm also assess the safety and pharmacokinetic profile of its back-up molecule ATX2417 in a phase I study. The company was incorporated on October 10, 2012 and is headquartered in Abingdon, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
F-star Alpha Ltd.
 F-star Alpha Ltd. BiotechnologyHealth Technology F-star Alpha Ltd. develops novel bispecific antibody products. It focuses on treatment of breast and gastric cancer among a population of HER2-positive patients who do not respond or become resistant to current therapies. The company was founded in October 2013 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
GeoSpock Ltd.
 GeoSpock Ltd. Data Processing ServicesTechnology Services GeoSpock Ltd. provides data software products. It offers illumin, extrapol and cogn8 products. The company was founded by Steven Marsh and Darrin Mathew Disley in 2013 and is headquartered in Cambridge, the United Kingdom. | Data Processing Services | Director/Board Member Director/Board Member | |
| HORIZON DISCOVERY GROUP PLC | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
Origami Energy Ltd.
 Origami Energy Ltd. Packaged SoftwareTechnology Services Origami Energy Ltd. develops and commercializes a technology platform for distributed energy applications. It offers technology and solutions to connect, control and manage a network of existing energy generating and energy storing assets connected to the electricity grid. The company was founded by Peter Bance in 2013 and is headquartered in London, the United Kingdom. | Packaged Software | Director/Board Member Director/Board Member | |
PhoreMost Ltd.
 PhoreMost Ltd. Pharmaceuticals: MajorHealth Technology PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can?t be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CMR Surgical Ltd.
 CMR Surgical Ltd. Medical SpecialtiesHealth Technology CMR Surgical Ltd. develops universal robotic system for minimal access surgery. The firm is presently evaluating the ability of the versius system to perform upper GI, gynaecological, colorectal and renal surgery in cadaveric trials. The company was founded by Martin Frost and Mark Slack in January 2014 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Founder Chairman Director/Board Member | |
Microbiotica Ltd.
 Microbiotica Ltd. BiotechnologyHealth Technology Microbiotica Ltd. performs research and experimental development on biotechnology. The company was founded by Michael Anthony Romanos, Trevor David Lawley and Gordon Dougan in December 2016 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Exvastat Ltd. operates as pharmaceutical company. The firm develops treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The company was founded by David Cavalla , Charlotte Summers and Andrew McElroy in 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Bicycle Therapeutics, Inc.
 Bicycle Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bicycle Therapeutics Plc, Bicycle Therapeutics, Inc. develops medicines and therapeutics for cancer treatment. The company is based in Lexington, MA. The company was founded in 2009 by Kevin Lee. Kevin Lee has been the CEO since 2009. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member | |
BicycleTx Ltd.
 BicycleTx Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2017, part of Bicycle Therapeutics Plc, BicycleTx Ltd. provides business support services. The company is based in Babraham, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Pheno Therapeutics Ltd.
 Pheno Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Pheno Therapeutics Ltd. operates as a biotechnology company. The firm develops remyelinating therapies for the unmet need for a neuroprotective therapy for multiple sclerosis. The company was founded on October 31, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
Altacor Ltd.
 Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
Ipsen Bioinnovation Ltd.
 Ipsen Bioinnovation Ltd. BiotechnologyHealth Technology Ipsen Bioinnovation Ltd. Engages in the research and development of pharmaceutical products. The company was founded in 2005 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
PetMedix Ltd.
 PetMedix Ltd. BiotechnologyHealth Technology Petmedix Ltd. engages in developing therapeutics industry. It focuses on animal health by developing antibody therapeutics. The company was founded by Thomas Weaver and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member Director/Board Member | |
Predictimmune Ltd.
 Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Medical Specialties | Chairman Director/Board Member | |
F-star Therapeutics Ltd.
 F-star Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology F-Star Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of immune-oncology drugs for antibody therapies. The company was founded in 2006 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member |
Statistieken
Internationaal
| Verenigd Koninkrijk | 36 |
| Verenigde Staten | 11 |
| Oostenrijk | 3 |
| Frankrijk | 2 |
| Canada | 2 |
Sectoraal
| Health Technology | 27 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 4 |
Operationeel
| Director/Board Member | 367 |
| Corporate Officer/Principal | 131 |
| Chairman | 81 |
| Founder | 68 |
| Chief Executive Officer | 63 |
Sterkste connecties
| Insiders | |
|---|---|
| Erik Langaker | 46 |
| Heiner Dreismann | 46 |
| Pierre Legault | 45 |
| Andrew Richards | 44 |
| Deborah Harland | 27 |
| Jonathan Milner | 26 |
| Charles Cotton | 24 |
| Jason Rhodes | 24 |
| Andrew Peter Sandham | 22 |
| Steven Leonard | 20 |
| Janice Bourque | 19 |
| Kieran Murphy | 19 |
| Victor Christou | 19 |
| Robert Tansley | 18 |
| Praveen K. Jain | 17 |
- Beurs
- Insiders
- Michael Anstey
- Bedrijfsconnecties
